Determination of a novel anti-psychotic agent AD-5423 and its metabolites in plasma by high-performance liquid chromatography with fluorescence detection

Journal of Pharmaceutical and Biomedical Analysis

Volumn 15, Issue 9-10, 1997, Pages 1449-1456

  Matsuda, Michiaki ^a   Sakashita, Motoko ^a   Yamaguchi, Toshikazu ^a   Fujii, Toshihiko ^a  

^a DAINIPPON SUMITOMO PHARMA CO LTD   (Japan)

Author keywords

AD 5423; AD 5423 metabolite; Anti psychotic agent; High performance liquid chromatography; Plasma; Simultaneous determination

Indexed keywords

BLONANSERIN; DRUG METABOLITE; NEUROLEPTIC AGENT;

ACCURACY; BLOOD ANALYSIS; CONFERENCE PAPER; CONTROLLED STUDY; DRUG DETERMINATION; FLUORESCENCE; HUMAN; PRIORITY JOURNAL; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SOLID PHASE EXTRACTION;

ADULT; ANIMALS; ANTIPSYCHOTIC AGENTS; CALIBRATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DOGS; HAPLORHINI; HUMANS; MALE; OXIDATION-REDUCTION; PIPERAZINES; PIPERIDINES; RATS; RATS, SPRAGUE-DAWLEY; REFERENCE STANDARDS; REFERENCE VALUES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SPECTROMETRY, FLUORESCENCE;

EID: 0030922393     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0731-7085(96)02037-7     Document Type: Conference Paper

References (7)

1. K. Hino, N. Kai, M. Sakamoto, T. Kon, M. Oka, K. Furukawa and Y. Ochi, EP 385237, JP 91007257, US 5021421.
2. M. Oka and K. Hino, Drugs Future, 17 (1992) 9-11.
3. Y. Noda, S. Kurumiya, Y. Miura et al., J. Pharmacol. Exp. Ther., 265 (1993) 745-751.
4. M. Oka, Y. Noda, Y. Ochi et al., J. Pharmacol. Exp. Ther., 264 (1993) 158-165.
5. F. Castelao, L. Ferreira, Y.G. Gelders et al., Schizophrenia Res., 2 (1989) 411-415.
6. T. Kato, A. Hirose, Y. Ohno et al., Jpn. J. Pharmacol., 54 (1990) 478-481.
7. T. Yamaguchi, M. Sakashita, H. Furukawa et al., Fifth North American ISSX Meet. Proc. 4, 1993, p. 68.